2025 Regular Session • Nevada Legislature
SB354: Revises provisions relating to health insurance coverage of prescription drugs. (BDR 57-1041)
Legislative Summary
AN ACT relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
3/13/2025
Read first time. Referred to Committee on Commerce and Labor. To printer.
Senate
3/17/2025
From printer. To committee.
Senate
4/21/2025
From committee: Amend, and do pass as amended.
Senate
4/21/2025
Placed on Second Reading File.
Senate
4/21/2025
Read second time. Amended. (Amend. No. 315.)
Senate
4/21/2025
Reprinting dispensed with.
Senate
4/22/2025
Notice of eligibility for exemption.
Senate
4/22/2025
Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.
Senate
4/25/2025
From printer. To engrossment. Engrossed. First reprint. To committee.
Senate
Amendments
Senate Amendment 315
Senate Amendment 315
Adopted
Status Information
Current Status
Introduced(3/13/2025)
Chamber
Senate
Committee
Finance(Senate)
Sponsors
Republican: 2
Democrat: 2
Primary Sponsor
Jeff Stone
Republican